Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Henry Schein, Inc.

HSICNASDAQ
Wall Street Score · overall investment33/100
$86.44USD+$1.48 (+1.74%)
Company website www.henryschein.com
Headquarters135 Duryea Road, Melville, NY, 11747, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Distribution
Price updated todayFinancials updated Oct 1, 2026

HSIC · Price history

Price at last available close

$86.44

+$2.47 (+2.94%) 1M

2026-10-29

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Henry Schein, Inc.

Primary reporting period: 2025-12-27 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services.

How they make money

Henry Schein operates as a global distributor of healthcare products and services, utilizing a centralized and automated distribution network to supply office-based dental and medical practitioners. The company generates revenue through the sale of branded and corporate-brand medical and dental supplies, equipment, and technology solutions, while also providing value-added services to improve clinical and operational outcomes for healthcare providers.

Products & services

The company provides over 300,000 products including dental and medical consumable supplies, equipment, practice management software, and technology-enabled value-added services for healthcare practitioners.

Brands & revenue mix

Henry Schein corporate brand

The company's proprietary line of products offered alongside third-party branded products.

Separate brand revenue is not available in this research.Source

Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.

Product / operating segments

No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

  • Office-based dental practitionersSource
  • Office-based medical practitionersSource
  • Dental laboratoriesSource
  • Government and institutional healthcare clinicsSource
  • Alternate care sitesSource

Customer concentration

The company does not disclose specific major customers, but notes that its top 10 suppliers accounted for approximately 24% of aggregate purchases in 2025.

Suppliers, materials & equipment

  • Global Distribution and Value-Added Services suppliers — The company's top 10 suppliers in this category accounted for approximately 24% of aggregate purchases, with the single largest supplier accounting for 4%. Specific supplier names are unnamed.Source

Business relationships & partnerships

  • KKR & Co. Inc. — A strategic partnership agreement involving a strategic investment by funds affiliated with KKR to pursue opportunities to create shareholder value.Source

Strengths

  • Centralized and automated distribution networkSource
  • Extensive portfolio of over 300,000 productsSource

Risks

  • Supply chain and distribution chain disruptionsSource
  • Interruption in production or supplier failure to comply with government requirementsSource
  • Cybersecurity risks and information technology system failuresSource

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

33

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

51

Fair

Financial Strength

43

Business Quality / Moat

51

Management

61

Growth Quality

39

Risk / Durability

77

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

31

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

38/100

Building Historical Record

Model Score 38/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Recent buyback activity is present
What to watch
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Debt / balance-sheet profile needs attention

Company-specific research

Questions worth answering for HSIC

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can HSIC maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is HSIC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is HSIC's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What future growth or profitability would be needed to justify HSIC's current valuation?
Business analysis: 17 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

33

0–100 · Poor

Opportunity Score

31

0–100 · Poor

Market Cap

$9.63B

P/E Ratio

24.3

EPS

$3.46

52-Week High

$92.18

52-Week Low

$61.95

Beta

0.81

Intrinsic Value

$39.07

Analyst Target

$95.00

Shares Outstanding

121.7M

Total Revenue

$13.60B

Total Debt

$3.81B

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$38.80

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
53/ 100
+4 pts / 5d

Neutral / mixed momentum

5D +0.5% · 20D +1.8% · RSI 60 · Price vs 20D avg +1.7%
Volatility
14/ 100
+1 pts / 5d

Low movement

20D realized vol 18.3% · 60D 18.1% · Acceleration 1.01x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for HSIC

Detected from reported data — verify before acting.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on HSIC.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Centralized and automated distribution network.
  • +Extensive portfolio of over 300,000 products.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Distribution industry.
  • −Supply chain and distribution chain disruptions.
  • −Interruption in production or supplier failure to comply with government requirements.
  • −Cybersecurity risks and information technology system failures.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak33/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

33

Tap for breakdown →

Weak

41

Debt Cost4.1%
Debt Reduction YoY-28.5%
Debt / Equity1.14x

Tap for breakdown →

Poor

26

Revenue YoY3.2%
Revenue CAGR3.4%
Net Margin3.0%

Tap for breakdown →

Fair

51

Asset Growth YoY9.8%
Liquidation/Share$38.80
Net Assets/MCap0.79x

Tap for breakdown →

Fair

51

Earnings Yield4.2%
Buyback Yield5.2%
Debt Cost4.1%

Tap for breakdown →

Fair

61

ROIC8.6%
ROE12.8%
ROA3.5%

Tap for breakdown →

Fair

51

EPS Growth1.0%
FCF/Share Growth2.2%
Rev/Share Growth6.5%

Tap for breakdown →

Poor

16

Intrinsic Value$39.07
Value Reference$23.44
MOS-117.5%

Tap for breakdown →

Weak

41

Revenue26
Moat51
Valuation16

Tap for breakdown →

Poor

0

MOS %-117.5%
Value Reference$23.44
Deep Discount Reference$15.63

Tap for breakdown →

Poor

34

Interest Coverage5.1x
ROIC8.6%
FCF Yield6.0%

Tap for breakdown →

Poor

27

Financial34
Valuation16
Debt41

Tap for breakdown →

Poor

35

Survival Years0.1 yrs
Current Ratio1.38x
FCF Margin4.3%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

3 historical score records available

Previous Score

33

Aug 14, 2026

Change

+0.7

points

Current Score

33

Oct 1, 2026

Category Changes

Revenue+1.3
Debt0
Assets+1.7
Capital+2.0
Management0
Moat0
Valuation+2.4
Buffett+0.7

HSIC increased 0.7 points because Capital improved by 2 points, Valuation improved by 2.4 points.

Positive Contributors

  • + Capital improved by 2 points
  • + Valuation improved by 2.4 points

Projected Score

Projected Score

39

Projected Change

+6.0 points

Preliminary comparable-period financial changes suggest improvement of approximately 6.0 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$86.44

Model Intrinsic Value

$39.07

Difference

+$47.37

+121.3% vs IV

Margin of Safety

-121.3%

UndervaluedFair ValueOvervalued
Value Reference: $23.44
Deep Discount Reference: $15.63

Financial Charts

Revenue

201420152016201720182019202020212022202320242025$0$3.5B$7.0B$10.5B$14.0B

Additional Metrics

Operating Cash Flow

201520172019202120232025$0$250M$500M$750M$1.0B

Total Debt

201520172019202120232025$0$950M$1.9B$2.9B$3.8B

Total Assets

201520172019202120232025$0$3.0B$6.0B$9.0B$12.0B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM2025202420232022202120202019201820172016
Revenue$13.60B$13.18B$12.67B$12.34B····························
Cost of Revenue$9.48B$9.34B$8.91B$8.69B····························
Gross Profit$4.12B$3.84B$3.77B$3.65B····························
Research & Development$0.00$0.00$0.00$0.00····························
SG&A Expenses$3.20B$3.08B$3.04B$2.94B····························
Operating Expenses$3.35B$3.08B$3.04B$2.94B····························
EBITDA$1.03B$1.01B$941.0M$877.0M····························
Operating Income$774.0M$758.0M$729.0M$714.0M····························
Interest Expense$159.0M$150.0M$131.0M$87.0M····························
Income Before Tax$558.0M$545.0M$526.0M$556.0M····························
Income Tax Expense$132.0M$126.0M$128.0M$120.0M····························
Net Income$403.0M$398.0M$390.0M$416.0M····························
Basic EPS$3.46$3.29$3.07$3.18····························
Basic Shares113M121M127M131M····························
Diluted Shares114M122M128M132M····························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:Nov 3, 2026
Estimated EPS: $1.34Estimated revenue: $3.47B
Jun 27, 2026Q2FY2026

Revenue

$3.46B

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.82

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

+13.5%

Cash Change

+8.3%

Margin Change

+0.1 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Margins expanded
  • Cash position grew

What Weakened

  • Debt increased

Potential Score Impact

Positive indicators included revenue growth, EPS growth, cash levels, net income margin. Pressure indicators included debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 6.7%. EPS increased 17.1%. Cash increased 8.3%. Total debt increased 13.5%. Net income margin improved by 0.1 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 125 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

44

Smart Money

44

Number of Gurus

4

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Loading data...

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Dividend data is not available yet. Missing data does not mean this company pays no dividend.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

3 historical records
Jul 23, 26Aug 14, 26Oct 1, 260255075100

Historical Score Chart

3 of 3 records shown

Wall Street Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Debt Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Revenue Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Asset Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Capital Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Management Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Moat Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Valuation Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Buffett Score

Jul 23, 26Aug 14, 26Oct 1, 260255075100

Intrinsic Value

Jul 23, 26Aug 14, 26Oct 1, 26$37.05$37.70$38.35$39.00$39.65

Value Reference

Jul 23, 26Aug 14, 26Oct 1, 26$22.05$22.40$22.75$23.10$23.45

Margin of Safety %

Jul 23, 26Aug 14, 26Oct 1, 26-3.0%-2.0%-1.0%0.0%1.0%

Related Companies

Medical - Distribution

RDGT

Ridgetech, Inc.

55Fair
$0.83View

MCK

McKesson Corporation

55Fair
$980.88View

COR

Cencora, Inc.

48Weak
$330.53View

CAH

Cardinal Health, Inc.

39Poor
$250.40View

EMPG

Empro Group Inc. Ordinary shares

35Poor
$17.36View

YI

111, Inc.

26Poor
$2.98View

News

Rumor Mill · HSIC

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial